Iovance Biotherapeutics (IOVA) Other financing activities (2015 - 2025)
Iovance Biotherapeutics (IOVA) posted quarterly Other financing activities of -$4.2 million for Q1 2026, up 25.96% year-over-year from -$3.3 million in Q1 2025, and down 800.65% quarter-over-quarter from -$464000.0 in Q3 2025.
Powered by 
Analysis
Iovance Biotherapeutics (IOVA) Other financing activities (2015 - 2025) Analysis & Trends
Iovance Biotherapeutics (IOVA) has reported Other financing activities for 12 consecutive years, with -$4.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Other financing activities rose 25.96% year-over-year to -$4.2 million; the TTM figure through Mar 2026 stood at -$5.1 million (up 81.11% YoY), while the FY2025 annual figure was $15000.0, up 100.12% from the prior year.
- Other financing activities fell to -$4.2 million in Q1 2026 per IOVA's latest filing, from -$464000.0 in the prior quarter.
- Across five years, Other financing activities topped out at $4.3 million in Q3 2022 and bottomed at -$14.3 million in Q4 2024.
- Historically, Other financing activities has averaged -$2.8 million across 5 years, with a median of -$2.6 million in 2022.
- Annual changes were most pronounced in 2022 — Other financing activities soared 146.54% — and 2024, when it sank 1556.2%.
- Iovance Biotherapeutics' Other financing activities stood at -$4.3 million in 2022, then soared by 33.58% to -$2.8 million in 2023, then tumbled by 402.63% to -$14.3 million in 2024, then soared by 96.76% to -$464000.0 in 2025, then sank by 800.65% to -$4.2 million in 2026.
- Business Quant data shows IOVA's Other financing activities at -$4.2 million in Q1 2026, -$464000.0 in Q3 2025, and -$504000.0 in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Iovance Biotherapeutics | 3.95 Bn | 3.66 Bn | 55.72 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | 15,000.00 |
| Dec 31, 2024 | 1.80 Mn |
| Sep 30, 2024 | 713,000.00 |
| Jun 30, 2024 | 390,000.00 |
| Mar 31, 2024 | 364,000.00 |
| Dec 31, 2023 | 8,000.00 |
| Jun 30, 2023 | 55,000.00 |
| Sep 30, 2022 | 225,000.00 |
| Jun 30, 2022 | -2.65 Mn |
| Mar 31, 2022 | 1.42 Mn |
| Dec 31, 2021 | 3.53 Mn |
| Sep 30, 2021 | 19.80 Mn |
| Jun 30, 2021 | 3.71 Mn |
| Mar 31, 2021 | 6.48 Mn |
| Dec 31, 2020 | 2.96 Mn |
| Sep 30, 2020 | 1.52 Mn |
| Jun 30, 2020 | -165,000.00 |
| Mar 31, 2020 | 3.95 Mn |
| Dec 31, 2019 | 2.21 Mn |
| Sep 30, 2019 | -99,000.00 |